{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:03:32Z","timestamp":1784937812345,"version":"3.55.0"},"reference-count":149,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/nrgastro.2016.132","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T11:13:57Z","timestamp":1473851637000},"page":"601-612","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["IgG4-related hepatobiliary disease: an overview"],"prefix":"10.1038","volume":"13","author":[{"given":"Emma L.","family":"Culver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger W.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,14]]},"reference":[{"key":"BFnrgastro2016132_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1053\/j.semdp.2012.08.002","volume":"29","author":"JH Stone","year":"2012","unstructured":"Stone, J. H. IgG4-related disease: nomenclature, clinical features, and treatment. Semin. Diagn. Pathol. 29, 177\u2013190 (2012).","journal-title":"Semin. Diagn. Pathol."},{"key":"BFnrgastro2016132_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1056\/NEJM196307042690102","volume":"269","author":"LG Bartholomew","year":"1963","unstructured":"Bartholomew, L. G., Cain, J. C., Woolner, L. B., Utz, D. C. & Ferris, D. O. Sclerosing cholangitis: its possible association with Riedel's struma and fibrous retroperitonitis. Report of two cases. N. Engl. J. Med. 269, 8\u201312 (1963).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016132_CR3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/BF02285209","volume":"40","author":"K Yoshida","year":"1995","unstructured":"Yoshida, K. et al. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig. Dis. Sci. 40, 1561\u20131568 (1995).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2016132_CR4","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1056\/NEJM200103083441005","volume":"344","author":"H Hamano","year":"2001","unstructured":"Hamano, H. et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N. Engl. J. Med. 344, 732\u2013738 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016132_CR5","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1111\/j.1572-0241.2003.08758.x","volume":"98","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa, T., Egawa, N. & Nakajima, H. Autoimmune pancreatitis is a systemic autoimmune disease. Am. J. Gastroenterol. 98, 2811\u20132812 (2003).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016132_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1053\/j.semdp.2012.07.005","volume":"29","author":"Y Zen","year":"2012","unstructured":"Zen, Y., Nakanuma, Y. & Portmann, B. Immunoglobulin G4-related sclerosing cholangitis: pathologic features and histologic mimics. Semin. Diagn. Pathol. 29, 205\u2013211 (2012).","journal-title":"Semin. Diagn. Pathol."},{"key":"BFnrgastro2016132_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/hep.21700","volume":"46","author":"T Umemura","year":"2007","unstructured":"Umemura, T. et al. Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 46, 463\u2013471 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro2016132_CR8","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1136\/gut.2007.122283","volume":"56","author":"T Umemura","year":"2007","unstructured":"Umemura, T. et al. IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis. Gut 56, 1471\u20131472 (2007).","journal-title":"Gut"},{"key":"BFnrgastro2016132_CR9","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00535-006-1908-9","volume":"41","author":"H Hamano","year":"2006","unstructured":"Hamano, H. et al. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J. Gastroenterol. 41, 1197\u20131205 (2006).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro2016132_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/MPA.0000000000000325","volume":"44","author":"A Kanno","year":"2015","unstructured":"Kanno, A. et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011. Pancreas 44, 535\u2013539 (2015).","journal-title":"Pancreas"},{"key":"BFnrgastro2016132_CR11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/MPA.0b013e3182480c99","volume":"41","author":"A Kanno","year":"2012","unstructured":"Kanno, A. et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan. Pancreas 41, 835\u2013839 (2012).","journal-title":"Pancreas"},{"key":"BFnrgastro2016132_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jhbp.50","volume":"21","author":"A Tanaka","year":"2014","unstructured":"Tanaka, A. et al. Nationwide survey for primary sclerosing cholangitis and IgG4-related sclerosing cholangitis in Japan. J. Hepatobiliary Pancreat. Sci. 21, 43\u201350 (2014).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"BFnrgastro2016132_CR13","doi-asserted-by":"publisher","unstructured":"Uchida, K., Masamune, A., Shimosegawa, T. & Okazaki, K. Prevalence of IgG4-Related Disease in Japan Based on Nationwide Survey in 2009. Int. J. Rheumatol. 2012, http:\/\/dx.doi.org\/10.1155\/2012\/358371 (2012).","DOI":"10.1155\/2012\/358371"},{"key":"BFnrgastro2016132_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","volume":"134","author":"A Ghazale","year":"2008","unstructured":"Ghazale, A. et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 134, 706\u2013715 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016132_CR15","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/ajg.2014.223","volume":"109","author":"MT Huggett","year":"2014","unstructured":"Huggett, M. T. et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am. J. Gastroenterol. 109, 1675\u20131683 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016132_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0046-8177(94)90176-7","volume":"25","author":"Y Nakanuma","year":"1994","unstructured":"Nakanuma, Y., Tsuneyama, K., Masuda, S. & Tomioka, T. Hepatic inflammatory pseudotumor associated with chronic cholangitis: report of three cases. Hum. Pathol. 25, 86\u201391 (1994).","journal-title":"Hum. Pathol."},{"key":"BFnrgastro2016132_CR17","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/hep.26999","volume":"60","author":"LJM de Buy Wenniger","year":"2014","unstructured":"de Buy Wenniger, L. J. M., Culver, E. L. & Beuers, U. Exposure to occupational antigens might predispose to IgG4-related disease. Hepatology 60, 1453\u20131454 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro2016132_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/all.12320","volume":"69","author":"E Della Torre","year":"2014","unstructured":"Della Torre, E. et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4-related disease. Allergy 69, 269\u2013272 (2014).","journal-title":"Allergy"},{"key":"BFnrgastro2016132_CR19","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/MEG.0b013e3283297417","volume":"21","author":"T Kamisawa","year":"2009","unstructured":"Kamisawa, T., Anjiki, H., Egawa, N. & Kubota, N. Allergic manifestations in autoimmune pancreatitis. Eur. J. Gastroenterol. Hepatol. 21, 1136\u20131139 (2009).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016132_CR20","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/all.12342","volume":"69","author":"H Mattoo","year":"2014","unstructured":"Mattoo, H., Della-Torre, E., Mahajan, V. S., Stone, J. H. & Pillai, S. Circulating Th2 memory cells in IgG4- related disease are restricted to a defined subset of subjects with atopy. Allergy 69, 399\u2013402 (2014).","journal-title":"Allergy"},{"key":"BFnrgastro2016132_CR21","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/ajg.2014.223","volume":"109","author":"MT Huggett","year":"2014","unstructured":"Huggett, M. T. et al. Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am. J. Gastroenterol. 109, 1675\u20131683 (2014).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016132_CR22","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/j.1440-1746.2010.06411.x","volume":"25","author":"H-C Oh","year":"2010","unstructured":"Oh, H.-C. et al. Clinical clues to suspicion of IgG4-associated sclerosing cholangitis disguised as primary sclerosing cholangitis or hilar cholangiocarcinoma. J. Gastroenterol. Hepatol. 25, 1831\u20131837 (2010).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016132_CR23","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/apt.12988","volume":"40","author":"D Joshi","year":"2014","unstructured":"Joshi, D. & Webster, G. J. M. Review article: Biliary and hepatic involvement in IgG4-related disease. Aliment. Pharmacol. Ther. 40, 1251\u20131261 (2014).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2016132_CR24","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/annrheumdis-2014-206405","volume":"74","author":"EL Culver","year":"2015","unstructured":"Culver, E. L. et al. Increased IgG4 responses to multiple food and animal antigens indicate a polyclonal expansion and differentiation of pre-existing B cells in IgG4-related disease. Ann. Rheum. Dis. 74, 944\u2013947 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016132_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/BOR.0b013e3283413469","volume":"23","author":"RP Sah","year":"2011","unstructured":"Sah, R. P. & Chari, S. T. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr. Opin. Rheumatol. 23, 108\u2013113 (2011).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrgastro2016132_CR26","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/hep.26977","volume":"59","author":"K Boonstra","year":"2014","unstructured":"Boonstra, K. et al. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology 59, 1954\u20131963 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro2016132_CR27","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","volume":"101","author":"FD Mendes","year":"2006","unstructured":"Mendes, F. D. et al. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis. Am. J. Gastroenterol. 101, 2070\u20132075 (2006).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016132_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers, M. N., Khosroshahi, A., Augustin, T., Deshpande, V. & Stone, J. H. The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann. Rheum. Dis. 74, 14\u201318 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016132_CR29","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/hep.24487","volume":"54","author":"AM Oseini","year":"2011","unstructured":"Oseini, A. M. et al. Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma. Hepatology 54, 940\u2013948 (2011).","journal-title":"Hepatology"},{"key":"BFnrgastro2016132_CR30","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1111\/jgh.12248","volume":"28","author":"H Ohara","year":"2013","unstructured":"Ohara, H. et al. Establishment of a serum IgG4 cut-off value for the differential diagnosis of IgG4-related sclerosing cholangitis: A Japanese cohort. J. Gastroenterol. Hepatol. 28, 1247\u20131251 (2013).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016132_CR31","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0016-5107(04)02229-1","volume":"60","author":"T Nakazawa","year":"2004","unstructured":"Nakazawa, T. et al. Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis. Gastrointest. Endosc. 60, 937\u2013944 (2004).","journal-title":"Gastrointest. Endosc."},{"key":"BFnrgastro2016132_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/01.mpa.0000202941.85955.07","volume":"32","author":"T Nakazawa","year":"2006","unstructured":"Nakazawa, T., Ohara, H., Sano, H., Ando, T. & Joh, T. Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas 32, 229 (2006).","journal-title":"Pancreas"},{"key":"BFnrgastro2016132_CR33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ajg.2016.40","volume":"111","author":"EL Culver","year":"2016","unstructured":"Culver, E. L. et al. Elevated serum IgG4 levels in diagnosis, treatment response, organ involvement and relapse in a prospective IgG4-related disease UK cohort. Am. J. Gastroenterol. 111, 733\u2013743 (2016).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016132_CR34","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/hep.28568","volume":"64","author":"ME Doorenspleet","year":"2016","unstructured":"Doorenspleet, M. E. et al. IgG4+ B-cell receptor clones distinguish IgG4-related disease from primary sclerosing cholangitis and biliary\/pancreatic malignancies. Hepatology 64, 501\u2013507 (2016).","journal-title":"Hepatology"},{"key":"BFnrgastro2016132_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","volume":"134","author":"H Mattoo","year":"2014","unstructured":"Mattoo, H. et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J. Allergy Clin. Immunol. 134, 679\u2013687 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrgastro2016132_CR36","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace, Z. S. et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann. Rheum. Dis. 74, 190\u2013195 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016132_CR37","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1136\/annrheumdis-2012-202893","volume":"72","author":"PF Kerkman","year":"2013","unstructured":"Kerkman, P. F. et al. Circulating plasmablasts\/plasmacells as a source of anticitrullinated protein antibodies in patients with rheumatoid arthritis. Ann. Rheum. Dis. 72, 1259\u20131263 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016132_CR38","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/art.10949","volume":"48","author":"AM Jacobi","year":"2003","unstructured":"Jacobi, A. M. et al. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 48, 1332\u20131342 (2003).","journal-title":"Arthritis Rheum."},{"issue":"Suppl. 2","key":"BFnrgastro2016132_CR39","first-page":"S646","volume":"64","author":"EL Culver","year":"2016","unstructured":"Culver, E. L. et al. Immunoglobulin E, eosinophils and mast cells in atopic individuals provide novel insights in IgG4-related disease. J. Hepatol. 64 (Suppl. 2), S646 (2016).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016132_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/MPA.0b013e31816b30e7","volume":"37","author":"R Koyama","year":"2008","unstructured":"Koyama, R. et al. Ultrasonographic imaging of bile duct lesions in autoimmune pancreatitis. Pancreas 37, 259\u2013264 (2008).","journal-title":"Pancreas"},{"key":"BFnrgastro2016132_CR41","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.crad.2009.07.006","volume":"64","author":"S Itoh","year":"2009","unstructured":"Itoh, S. et al. Lymphoplasmacytic sclerosing cholangitis: assessment of clinical, CT, and pathological findings. Clin. Radiol. 64, 1104\u20131114 (2009).","journal-title":"Clin. Radiol."},{"key":"BFnrgastro2016132_CR42","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00534-012-0521-y","volume":"19","author":"H Ohara","year":"2012","unstructured":"Ohara, H. et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012. J. Hepatobiliary Pancreat. Sci. 19, 536\u2013542 (2012).","journal-title":"J. Hepatobiliary Pancreat. Sci."},{"key":"BFnrgastro2016132_CR43","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2214\/AJR.12.10360","volume":"202","author":"A Tokala","year":"2014","unstructured":"Tokala, A., Khalili, K., Menezes, R., Hirschfield, G. & Jhaveri, K. S. Comparative MRI analysis of morphologic patterns of bile duct disease in IgG4-related systemic disease versus primary sclerosing cholangitis. AJR. Am. J. Roentgenol. 202, 536\u2013543 (2014).","journal-title":"AJR. Am. J. Roentgenol."},{"key":"BFnrgastro2016132_CR44","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00535-010-0319-0","volume":"46","author":"I Naitoh","year":"2011","unstructured":"Naitoh, I. et al. Small bile duct involvement in IgG4-related sclerosing cholangitis: Liver biopsy and cholangiography correlation. J. Gastroenterol. 46, 269\u2013276 (2011).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro2016132_CR45","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1007\/s00259-014-2729-3","volume":"41","author":"J Zhang","year":"2014","unstructured":"Zhang, J. et al. Characterizing IgG4-related disease with 18F-FDG PET\/CT: a prospective cohort study. Eur. J. Nucl. Med. Mol. Imaging 41, 1624\u20131634 (2014).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"BFnrgastro2016132_CR46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.5009\/gnl.2013.7.2.234","volume":"7","author":"T Tabata","year":"2013","unstructured":"Tabata, T. et al. Differentiating immunoglobulin g4-related sclerosing cholangitis from hilar cholangiocarcinoma. Gut Liver 7, 234\u2013238 (2013).","journal-title":"Gut Liver"},{"key":"BFnrgastro2016132_CR47","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.cgh.2011.05.019","volume":"9","author":"E Kalaitzakis","year":"2011","unstructured":"Kalaitzakis, E. et al. Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin. Gastroenterol. Hepatol. 9, 800\u2013803.e2 (2011).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016132_CR48","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.gie.2010.03.1132","volume":"72","author":"H Kawakami","year":"2010","unstructured":"Kawakami, H. & Zen, Y. Is IgG4 immunostaining of duodenal ampullary biopsies alone useful to diagnose autoimmune pancreatitis? Gastrointest. Endosc. 72, 1328; author reply 1328\u20131329 (2010).","journal-title":"Gastrointest. Endosc."},{"key":"BFnrgastro2016132_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1443-1661.2012.01276.x","volume":"24","author":"N Okano","year":"2012","unstructured":"Okano, N., Igarashi, Y., Kishimoto, Y., Ito, K., Sasai, D. Case of immunoglobulin G4-related cholangitis accompanying autoimmune pancreatitis: diagnosis by peroral cholangioscopy and treatment by endoscopic biliary stenting. Dig. Endosc. 24, 62\u201366 (2012).","journal-title":"Dig. Endosc."},{"key":"BFnrgastro2016132_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.5946\/ce.2012.45.3.331","volume":"45","author":"T Nakazawa","year":"2012","unstructured":"Nakazawa, T., Naitoh, I. & Hayashi, K. Usefulness of intraductal ultrasonography in the diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis. Clin. Endosc. 45, 331 (2012).","journal-title":"Clin. Endosc."},{"key":"BFnrgastro2016132_CR51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/1751-2980.12311","volume":"17","author":"I Naitoh","year":"2016","unstructured":"Naitoh, I. et al. Predictive factors for positive diagnosis of malignant biliary strictures by transpapillary brush cytology and forceps biopsy. J. Dig. Dis. 17, 44\u201351 (2016).","journal-title":"J. Dig. Dis."},{"key":"BFnrgastro2016132_CR52","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cgh.2010.06.029","volume":"8","author":"T Itoi","year":"2010","unstructured":"Itoi, T. et al. Diagnostic peroral video cholangioscopy is an accurate diagnostic tool for patients with bile duct lesions. Clin. Gastroenterol. Hepatol. 8, 934\u2013938 (2010).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016132_CR53","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.gie.2009.12.004","volume":"71","author":"S-H Moon","year":"2010","unstructured":"Moon, S.-H. et al. IgG4 immunostaining of duodenal papillary biopsy specimens may be useful for supporting a diagnosis of autoimmune pancreatitis. Gastrointest. Endosc. 71, 960\u2013966 (2010).","journal-title":"Gastrointest. Endosc."},{"key":"BFnrgastro2016132_CR54","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1309\/AJCPT00NHQHXAHDS","volume":"139","author":"KM Cebe","year":"2013","unstructured":"Cebe, K. M., Swanson, P. E., Upton, M. P. & Westerhoff, M. Increased IgG4+ cells in duodenal biopsies are not specific for autoimmune pancreatitis. Am. J. Clin. Pathol. 139, 323\u2013329 (2013).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrgastro2016132_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-0030-1256872","volume":"44","author":"K Vosskuhl","year":"2012","unstructured":"Vosskuhl, K. et al. Measurement of IgG4 in bile: A new approach for the diagnosis of IgG4-associated cholangiopathy. Endoscopy 44, 48\u201352 (2012).","journal-title":"Endoscopy"},{"key":"BFnrgastro2016132_CR56","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/art.34593","volume":"64","author":"JHJR Stone","year":"2012","unstructured":"Stone, J. H. J. R. et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum. 64, 3061\u20133067 (2012).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016132_CR57","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/modpathol.2009.94","volume":"22","author":"V Deshpande","year":"2009","unstructured":"Deshpande, V. et al. IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod. Pathol. 22, 1287\u20131295 (2009).","journal-title":"Mod. Pathol."},{"key":"BFnrgastro2016132_CR58","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/jclinpath-2012-200932","volume":"65","author":"EL Culver","year":"2012","unstructured":"Culver, E. L. & Bateman, A. C. IgG4-related disease: can non-classical histopathological features or the examination of clinically uninvolved tissues be helpful in the diagnosis? J. Clin. Pathol. 65, 963\u2013969 (2012).","journal-title":"J. Clin. Pathol."},{"key":"BFnrgastro2016132_CR59","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00535-009-0108-9","volume":"44","author":"I Naitoh","year":"2009","unstructured":"Naitoh, I. et al. Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis. J. Gastroenterol. 44, 1147\u20131155 (2009).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro2016132_CR60","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande, V. et al. Consensus statement on the pathology of IgG4-related disease. Mod. Pathol. 25, 1181\u20131192 (2012).","journal-title":"Mod. Pathol."},{"key":"BFnrgastro2016132_CR61","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/PAS.0b013e3181c6c09a","volume":"34","author":"L Zhang","year":"2010","unstructured":"Zhang, L. et al. IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Am. J. Surg. Pathol. 34, 88\u201394 (2010).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrgastro2016132_CR62","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1365-2559.2011.03763.x","volume":"58","author":"Y Zen","year":"2011","unstructured":"Zen, Y., Quaglia, A. & Portmann, B. Immunoglobulin G4-positive plasma cell infiltration in explanted livers for primary sclerosing cholangitis. Histopathology 58, 414\u2013422 (2011).","journal-title":"Histopathology"},{"key":"BFnrgastro2016132_CR63","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/hep.25627","volume":"56","author":"K Harada","year":"2012","unstructured":"Harada, K. et al. Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: molecular mechanism of IgG4 reaction in cancer tissue. Hepatology 56, 157\u2013164 (2012).","journal-title":"Hepatology"},{"key":"BFnrgastro2016132_CR64","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1136\/jcp.2010.085613","volume":"64","author":"JD Strehl","year":"2011","unstructured":"Strehl, J. D., Hartmann, A. & Agaimy, A. Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders. J. Clin. Pathol. 64, 237\u2013243 (2011).","journal-title":"J. Clin. Pathol."},{"key":"BFnrgastro2016132_CR65","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/modpathol.3800836","volume":"20","author":"Y Zen","year":"2007","unstructured":"Zen, Y., Fujii, T., Sato, Y., Masuda, S. & Nakanuma, Y. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod. Pathol. 20, 884\u2013894 (2007).","journal-title":"Mod. Pathol."},{"key":"BFnrgastro2016132_CR66","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1478-3231.2009.02092.x","volume":"30","author":"H Chung","year":"2010","unstructured":"Chung, H. et al. Identification and characterization of IgG4-associated autoimmune hepatitis. Liver Int. 30, 222\u2013231 (2010).","journal-title":"Liver Int."},{"key":"BFnrgastro2016132_CR67","doi-asserted-by":"publisher","first-page":"7661","DOI":"10.3748\/wjg.v19.i43.7661","volume":"19","author":"T Nakazawa","year":"2013","unstructured":"Nakazawa, T. et al. Diagnosis of IgG4-related sclerosing cholangitis. World J. Gastroenterol. 19, 7661\u20137670 (2013).","journal-title":"World J. Gastroenterol."},{"issue":"Suppl. 1","key":"BFnrgastro2016132_CR68","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00535-007-2046-8","volume":"42","author":"ST Chari","year":"2007","unstructured":"Chari, S. T. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic's HISORt criteria. J. Gastroenterol. 42 (Suppl. 1), 39\u201341 (2007).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro2016132_CR69","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/art.39132","volume":"67","author":"A Khosroshahi","year":"2015","unstructured":"Khosroshahi, A. et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol. 67, 1688\u20131699 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrgastro2016132_CR70","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/gut.2008.172908","volume":"58","author":"T Kamisawa","year":"2009","unstructured":"Kamisawa, T. et al. Standard steroid treatment for autoimmune pancreatitis. Gut 58, 1504\u20131507 (2009).","journal-title":"Gut"},{"key":"BFnrgastro2016132_CR71","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/MPA.0000000000000044","volume":"43","author":"J Buijs","year":"2014","unstructured":"Buijs, J. et al. Comparable efficacy of low- versus high-dose induction corticosteroid treatment in autoimmune pancreatitis. Pancreas 43, 261\u2013267 (2014).","journal-title":"Pancreas"},{"key":"BFnrgastro2016132_CR72","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/gut.2008.150979","volume":"57","author":"S-H Moon","year":"2008","unstructured":"Moon, S.-H. et al. Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut 57, 1704\u20131712 (2008).","journal-title":"Gut"},{"key":"BFnrgastro2016132_CR73","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart, P. A. et al. Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut 62, 1771\u20131776 (2013).","journal-title":"Gut"},{"key":"BFnrgastro2016132_CR74","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.cgh.2009.03.021","volume":"7","author":"NS Sandanayake","year":"2009","unstructured":"Sandanayake, N. S. et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis\/immunoglobulin G4-associated cholangitis. Clin. Gastroenterol. Hepatol. 7, 1089\u20131096 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016132_CR75","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/gutjnl-2012-302886","volume":"62","author":"PA Hart","year":"2013","unstructured":"Hart, P. A. et al. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Gut 62, 1607\u20131615 (2013).","journal-title":"Gut"},{"key":"BFnrgastro2016132_CR76","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.cgh.2007.12.020","volume":"6","author":"M Topazian","year":"2008","unstructured":"Topazian, M. et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin. Gastroenterol. Hepatol. 6, 364\u2013366 (2008).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016132_CR77","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers, M. N. et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann. Rheum. Dis. 74, 1171\u20131177 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016132_CR78","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/MEG.0b013e3283431e23","volume":"23","author":"K Takuma","year":"2011","unstructured":"Takuma, K. et al. Short-term and long-term outcomes of autoimmune pancreatitis. Eur. J. Gastroenterol. Hepatol. 23, 146\u2013152 (2011).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016132_CR79","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3109\/s10165-011-0520-x","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto, M. et al. Risk of malignancies in IgG4-related disease. Mod. Rheumatol. 22, 414\u2013418 (2012).","journal-title":"Mod. Rheumatol."},{"key":"BFnrgastro2016132_CR80","doi-asserted-by":"crossref","first-page":"722","DOI":"10.4049\/jimmunol.130.2.722","volume":"130","author":"RC Aalberse","year":"1983","unstructured":"Aalberse, R. C., van der Gaag, R. & van Leeuwen, J. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J. Immunol. 130, 722\u2013726 (1983).","journal-title":"J. Immunol."},{"key":"BFnrgastro2016132_CR81","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1365-2222.2009.03207.x","volume":"39","author":"RC Aalberse","year":"2009","unstructured":"Aalberse, R. C., Stapel, S. O., Schuurman, J. & Rispens, T. Immunoglobulin G4: an odd antibody. Clin. Exp. Allergy 39, 469\u2013477 (2009).","journal-title":"Clin. Exp. Allergy"},{"key":"BFnrgastro2016132_CR82","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/gast.2002.33022","volume":"122","author":"S Kawa","year":"2002","unstructured":"Kawa, S. et al. HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 122, 1264\u20131269 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016132_CR83","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.gastro.2007.11.023","volume":"134","author":"DH Park","year":"2008","unstructured":"Park, D. H. et al. Substitution of aspartic acid at position 57 of the DQ\u03b21 affects relapse of autoimmune pancreatitis. Gastroenterology 134, 440\u2013446 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016132_CR84","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00535-009-0080-4","volume":"44","author":"K Hirano","year":"2009","unstructured":"Hirano, K. et al. No significant relation between relapse of autoimmune pancreatitis and substitution of aspartic acid at position 57 of DQ\u03b21. J. Gastroenterol. 44, 799\u2013800 (2009).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro2016132_CR85","first-page":"S646","volume":"64","author":"EL Culver","year":"2016","unstructured":"Culver, E. L. et al. Human leucocyte antigen associations in IgG4-related disease and primary sclerosing cholangitis stratified by IgG4 levels, in a multicenter UK cohort. J. Hepatol. 64, S646 (2016).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016132_CR86","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/j.1572-0241.2007.01750.x","volume":"103","author":"T Umemura","year":"2008","unstructured":"Umemura, T. et al. Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am. J. Gastroenterol. 103, 588\u2013594 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016132_CR87","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1136\/gut.2006.095059","volume":"55","author":"T Umemura","year":"2006","unstructured":"Umemura, T. et al. Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 55, 1367\u20131368 (2006).","journal-title":"Gut"},{"key":"BFnrgastro2016132_CR88","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1373\/clinchem.2007.085951","volume":"53","author":"M-C Chang","year":"2007","unstructured":"Chang, M.-C. et al. T-Cell regulatory gene CTLA-4 polymorphism\/haplotype association with autoimmune pancreatitis. Clin. Chem. 53, 1700\u20131705 (2007).","journal-title":"Clin. Chem."},{"key":"BFnrgastro2016132_CR89","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/hep.26232","volume":"57","author":"LJ Maillette de Buy Wenniger","year":"2013","unstructured":"Maillette de Buy Wenniger, L. J. et al. Immunoglobulin G4+ clones identified by next-generation sequencing dominate the B cell receptor repertoire in immunoglobulin G4 associated cholangitis. Hepatology 57, 2390\u20132398 (2013).","journal-title":"Hepatology"},{"key":"BFnrgastro2016132_CR90","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/01.mpa.0000226881.48204.fd","volume":"33","author":"M Asada","year":"2006","unstructured":"Asada, M. et al. Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas 33, 20\u201326 (2006).","journal-title":"Pancreas"},{"key":"BFnrgastro2016132_CR91","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/gut.2004.047142","volume":"54","author":"L Aparisi","year":"2005","unstructured":"Aparisi, L. et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 54, 703\u2013709 (2005).","journal-title":"Gut"},{"key":"BFnrgastro2016132_CR92","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1136\/gut.2004.049064","volume":"54","author":"I Nishimori","year":"2005","unstructured":"Nishimori, I. et al. Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut 54, 274\u2013281 (2005).","journal-title":"Gut"},{"key":"BFnrgastro2016132_CR93","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/ajg.2010.141","volume":"105","author":"J-M L\u00f6hr","year":"2010","unstructured":"L\u00f6hr, J.-M. et al. Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am. J. Gastroenterol. 105, 2060\u20132071 (2010).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2016132_CR94","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1582-4934.2005.tb00506.x","volume":"9","author":"F Guarneri","year":"2005","unstructured":"Guarneri, F., Guarneri, C. & Benvenga, S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J. Cell. Mol. Med. 9, 741\u2013744 (2005).","journal-title":"J. Cell. Mol. Med."},{"key":"BFnrgastro2016132_CR95","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1582-4934.2005.tb00349.x","volume":"9","author":"J Kountouras","year":"2005","unstructured":"Kountouras, J., Zavos, C. & Chatzopoulos, D. A concept on the role of Helicobacter pylori infection in autoimmune pancreatitis. J. Cell. Mol. Med. 9, 196\u2013207 (2005).","journal-title":"J. Cell. Mol. Med."},{"key":"BFnrgastro2016132_CR96","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1056\/NEJMoa0903068","volume":"361","author":"L Frulloni","year":"2009","unstructured":"Frulloni, L. et al. Identification of a novel antibody associated with autoimmune pancreatitis. N. Engl. J. Med. 361, 2135\u20132142 (2009).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2016132_CR97","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1159\/000264677","volume":"10","author":"R Jesnowski","year":"2010","unstructured":"Jesnowski, R. et al. Helicobacter pylori in autoimmune pancreatitis and pancreatic carcinoma. Pancreatology 10, 462\u2013466 (2010).","journal-title":"Pancreatology"},{"key":"BFnrgastro2016132_CR98","doi-asserted-by":"publisher","first-page":"S644","DOI":"10.1016\/S0168-8278(16)01201-0","volume":"64","author":"EL Culver","year":"2016","unstructured":"Culver, E. L. et al. Helicobacter Pylori as a microbial antigen in IgG4-related disease. J. Hepatol. 64, S644 (2016).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016132_CR99","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1365-2559.2005.02204.x","volume":"47","author":"S Aoki","year":"2005","unstructured":"Aoki, S. et al. Immunohistochemical study of autoimmune pancreatitis using anti-IgG4 antibody and patients' sera. Histopathology 47, 147\u2013158 (2005).","journal-title":"Histopathology"},{"key":"BFnrgastro2016132_CR100","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1136\/gutjnl-2015-310336","volume":"65","author":"M Shiokawa","year":"2016","unstructured":"Shiokawa, M. et al. Pathogenicity of IgG in patients with IgG4-related disease. Gut 65, 1322\u20131332 (2016).","journal-title":"Gut"},{"key":"BFnrgastro2016132_CR101","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/hep.21697","volume":"45","author":"Y Zen","year":"2007","unstructured":"Zen, Y. et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45, 1538\u20131546 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro2016132_CR102","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1053\/j.gastro.2013.01.055","volume":"144","author":"T M\u00fcller","year":"2013","unstructured":"M\u00fcller, T. et al. Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction\u2013associated biliary epithelial cell barrier. Gastroenterology 144, 1116\u20131128 (2013).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016132_CR103","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/hep.21697","volume":"45","author":"Y Zen","year":"2007","unstructured":"Zen, Y. et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 45, 1538\u20131546 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro2016132_CR104","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/art.33320","volume":"64","author":"A Tanaka","year":"2012","unstructured":"Tanaka, A. et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum. 64, 254\u2013263 (2012).","journal-title":"Arthritis Rheum."},{"issue":"Suppl. 1","key":"BFnrgastro2016132_CR105","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000312125","volume":"152","author":"H Kanari","year":"2010","unstructured":"Kanari, H. et al. Role of Th2 cells in IgG4-related lacrimal gland enlargement. Int. Arch. Allergy Immunol. 152 (Suppl. 1), 47\u201353 (2010).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"BFnrgastro2016132_CR106","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/modpathol.2013.236","volume":"27","author":"M Takeuchi","year":"2014","unstructured":"Takeuchi, M. et al. T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease. Mod. Pathol. 27, 1126\u20131136 (2014).","journal-title":"Mod. Pathol."},{"key":"BFnrgastro2016132_CR107","doi-asserted-by":"publisher","unstructured":"Takeuchi, M. et al. Interleukin 13-positive mast cells are increased in immunoglobulin G4-related sialadenitis. Sci. Rep. 5, http:\/\/dx.doi.org\/10.1038\/srep07696 (2015).","DOI":"10.1038\/srep07696"},{"key":"BFnrgastro2016132_CR108","doi-asserted-by":"publisher","unstructured":"Tsuboi, H. et al. Analysis of IgG4 class switch-related molecules in IgG4-related disease. Arthritis Res. Ther. 14, http:\/\/dx.doi.org\/10.1186\/ar3924 (2012).","DOI":"10.1186\/ar3924"},{"key":"BFnrgastro2016132_CR109","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/MPA.0b013e3181577553","volume":"36","author":"H Miyoshi","year":"2008","unstructured":"Miyoshi, H. et al. Circulating na\u00efve and CD4+CD25high regulatory T cells in patients with autoimmune pancreatitis. Pancreas 36, 133\u2013140 (2008).","journal-title":"Pancreas"},{"key":"BFnrgastro2016132_CR110","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1097\/MPA.0b013e31821fc796","volume":"40","author":"T Kusuda","year":"2011","unstructured":"Kusuda, T. et al. Involvement of inducible costimulator- and interleukin 10-positive regulatory T cells in the development of IgG4-related autoimmune pancreatitis. Pancreas 40, 1120\u20131130 (2011).","journal-title":"Pancreas"},{"key":"BFnrgastro2016132_CR111","doi-asserted-by":"publisher","unstructured":"Uchida, K. et al. Regulatory T cells in type 1 autoimmune pancreatitis. Int. J. Rheumatol. 2012, http:\/\/dx.doi.org\/10.1155\/2012\/795026 (2012).","DOI":"10.1155\/2012\/795026"},{"key":"BFnrgastro2016132_CR112","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/art.39209","volume":"67","author":"M Akiyama","year":"2015","unstructured":"Akiyama, M. et al. Number of circulating follicular helper 2 T cells correlates with IgG4 and interleukin-4 levels and plasmablast numbers in IgG4-related disease. Arthritis Rheumatol. 67, 2476\u20132481 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"BFnrgastro2016132_CR113","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","volume":"34","author":"R Morita","year":"2012","unstructured":"Morita, R. et al. Human blood CXCR5+CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 34, 108\u2013121 (2012).","journal-title":"Immunity"},{"key":"BFnrgastro2016132_CR114","doi-asserted-by":"publisher","unstructured":"Esposito, I. et al. Autoimmune pancreatocholangitis, non-autoimmune pancreatitis and primary sclerosing cholangitis: a comparative morphological and immunological analysis. PLoS ONE 3, http:\/\/dx.doi.org\/10.1371\/journal.pone.0002539 (2008).","DOI":"10.1371\/journal.pone.0002539"},{"key":"BFnrgastro2016132_CR115","doi-asserted-by":"publisher","unstructured":"Mattoo, H. et al. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J. Allergy Clin. Immunol. http:\/\/dx.doi.org\/10.1016\/j.jaci.2015.12.1330 (2016).","DOI":"10.1016\/j.jaci.2015.12.1330"},{"key":"BFnrgastro2016132_CR116","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jaci.2013.07.044","volume":"133","author":"LC Lighaam","year":"2014","unstructured":"Lighaam, L. C. et al. Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response. J. Allergy Clin. Immunol. 133, 267\u2013270. e1\u20136 (2014).","journal-title":"J. Allergy Clin. Immunol."},{"key":"BFnrgastro2016132_CR117","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.humpath.2014.04.006","volume":"45","author":"RPD Graham","year":"2014","unstructured":"Graham, R. P. D., Smyrk, T. C., Chari, S. T., Takahashi, N. & Zhang, L. Isolated IgG4-related sclerosing cholangitis: a report of 9 cases. Hum. Pathol. 45, 1722\u20131729 (2014).","journal-title":"Hum. Pathol."},{"key":"BFnrgastro2016132_CR118","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jhep.2013.06.016","volume":"59","author":"Y Zen","year":"2013","unstructured":"Zen, Y., Liberal, R., Nakanuma, Y., Heaton, N. & Portmann, B. Possible involvement of CCL1-CCR8 interaction in lymphocytic recruitment in IgG4-related sclerosing cholangitis. J. Hepatol. 59, 1059\u20131064 (2013).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016132_CR119","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1053\/j.gastro.2012.07.112","volume":"143","author":"GM Seleznik","year":"2012","unstructured":"Seleznik, G. M. et al. Lymphotoxin \u03b2 receptor signaling promotes development of autoimmune pancreatitis. Gastroenterology 143, 1361\u20131374 (2012).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016132_CR120","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1016\/S0168-8278(14)60517-1","volume":"60","author":"EL Culver","year":"2014","unstructured":"Culver, E. L. et al. Gene expression analysis identifies immune signaling and complment pathways in IgG4-related disease. J. Hepatol. 60, S185\u2013S186 (2014).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016132_CR121","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/gut.2009.200972","volume":"59","author":"R Akitake","year":"2010","unstructured":"Akitake, R. et al. Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease. Gut 59, 542\u2013545 (2010).","journal-title":"Gut"},{"key":"BFnrgastro2016132_CR122","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00535-012-0626-8","volume":"48","author":"T Watanabe","year":"2013","unstructured":"Watanabe, T. et al. Toll-like receptor activation in basophils contributes to the development of IgG4-related disease. J. Gastroenterol. 48, 247\u2013253 (2013).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro2016132_CR123","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clim.2014.10.008","volume":"156","author":"S Furukawa","year":"2015","unstructured":"Furukawa, S. et al. Preferential M2 macrophages contribute to fibrosis in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease. Clin. Immunol. 156, 9\u201318 (2015).","journal-title":"Clin. Immunol."},{"key":"BFnrgastro2016132_CR124","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/art.27435","volume":"62","author":"A Khosroshahi","year":"2010","unstructured":"Khosroshahi, A., Bloch, D. B., Deshpande, V. & Stone, J. H. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 62, 1755\u20131762 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2016132_CR125","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/MD.0b013e3182431ef6","volume":"91","author":"A Khosroshahi","year":"2012","unstructured":"Khosroshahi, A. et al. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 91, 57\u201366 (2012).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2016132_CR126","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers, M. N. et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann. Rheum. Dis. 74, 1171\u20131177 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016132_CR127","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace, Z. S. et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann. Rheum. Dis. 74, 190\u2013195 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016132_CR128","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1136\/annrheumdis-2014-205799","volume":"74","author":"E Della-Torre","year":"2015","unstructured":"Della-Torre, E. et al. B-Cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann. Rheum. Dis. 74, 2236\u20132243 (2015).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2016132_CR129","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0014-5793(99)01251-X","volume":"459","author":"K Nagata","year":"1999","unstructured":"Nagata, K. et al. CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett. 459, 195\u2013199 (1999).","journal-title":"FEBS Lett."},{"issue":"Suppl.","key":"BFnrgastro2016132_CR130","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000337761","volume":"158","author":"Y Saito","year":"2012","unstructured":"Saito, Y. et al. Roles of CRTH2+ CD4+ T cells in immunoglobulin G4-related lacrimal gland enlargement. Int. Arch. Allergy Immunol. 158 (Suppl.), 42\u201346 (2012).","journal-title":"Int. Arch. Allergy Immunol."},{"key":"BFnrgastro2016132_CR131","doi-asserted-by":"publisher","first-page":"e86689","DOI":"10.1172\/jci.insight.86689","volume":"1","author":"T Huang","year":"2016","unstructured":"Huang, T. et al. Depletion of major pathogenic cells in asthma by targeting CRTh2. JCI Insight. 1, e86689 (2016).","journal-title":"JCI Insight."},{"key":"BFnrgastro2016132_CR132","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2009.09.018","volume":"51","author":"U Beuers","year":"2009","unstructured":"Beuers, U., Boberg, K. M. & Chapman, R. W. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J. Hepatol. 51, 237\u2013267 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016132_CR133","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande, V. et al. Consensus statement on the pathology of IgG4-related disease. Mod. Pathol. 25, 1181\u20131192 (2012).","journal-title":"Mod. Pathol."},{"key":"BFnrgastro2016132_CR134","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/kev203","volume":"54","author":"W Lin","year":"2015","unstructured":"Lin, W. et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients. Rheumatology (Oxford) 54, 1982\u20131990 (2015).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrgastro2016132_CR135","doi-asserted-by":"publisher","unstructured":"Inoue, D. et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore) 94, http:\/\/dx.doi.org\/10.1097\/MD.0000000000000680 (2015).","DOI":"10.1097\/MD.0000000000000680"},{"key":"BFnrgastro2016132_CR136","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Codina, A. et al. IgG4-related disease: results from a multicenter Spanish registry. Medicine (Baltimore) 94, http:\/\/dx.doi.org\/10.1097\/MD.0000000000001275 (2015).","DOI":"10.1097\/MD.0000000000001275"},{"key":"BFnrgastro2016132_CR137","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","volume":"45","author":"C Campochiaro","year":"2015","unstructured":"Campochiaro, C. et al. IgG4-related disease in Italy: clinical features and outcomes of a large cohort of patients. Scand. J. Rheumatol. 45, 135\u2013145 (2015).","journal-title":"Scand. J. Rheumatol."},{"issue":"Suppl. 3","key":"BFnrgastro2016132_CR138","doi-asserted-by":"publisher","first-page":"S478","DOI":"10.1111\/j.1872-034X.2007.00243.x","volume":"37","author":"Y Nakanuma","year":"2007","unstructured":"Nakanuma, Y. & Zen, Y. Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: The latest addition to the sclerosing cholangitis family. Hepatol. Res. 37 (Suppl. 3), S478\u2013486 (2007).","journal-title":"Hepatol. Res."},{"key":"BFnrgastro2016132_CR139","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/ibd.20898","volume":"15","author":"K Ravi","year":"2009","unstructured":"Ravi, K. et al. Inflammatory bowel disease in the setting of autoimmune pancreatitis. Inflamm. Bowel Dis. 15, 1326\u20131330 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2016132_CR140","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/ibd.21219","volume":"16","author":"U Navaneethan","year":"2010","unstructured":"Navaneethan, U. & Shen, B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm. Bowel Dis. 16, 1598\u20131619 (2010).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2016132_CR141","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jhep.2009.04.010","volume":"51","author":"GJM Webster","year":"2009","unstructured":"Webster, G. J. M., Pereira, S. P. & Chapman, R. W. Autoimmune pancreatitis\/IgG4-associated cholangitis and primary sclerosing cholangitis\u2014overlapping or separate diseases? J. Hepatol. 51, 398\u2013402 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrgastro2016132_CR142","doi-asserted-by":"publisher","unstructured":"Stinton, L. M. et al. PR3-ANCA: a promising biomarker in primary sclerosing cholangitis (PSC). PLoS ONE 9, http:\/\/dx.doi.org\/10.1371\/journal.pone.0112877 (2014).","DOI":"10.1371\/journal.pone.0112877"},{"key":"BFnrgastro2016132_CR143","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1002\/hep.26977","volume":"59","author":"K Boonstra","year":"2014","unstructured":"Boonstra, K. et al. Serum immunoglobulin G4 and immunoglobulin G1 for distinguishing immunoglobulin G4-associated cholangitis from primary sclerosing cholangitis. Hepatology 59, 1954\u20131963 (2014).","journal-title":"Hepatology"},{"key":"BFnrgastro2016132_CR144","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1053\/j.gastro.2015.01.041","volume":"148","author":"NL Berntsen","year":"2015","unstructured":"Berntsen, N. L. et al. Association between HLA haplotypes and increased serum levels of IgG4 in patients with primary sclerosing cholangitis. Gastroenterology 148, 924\u2013927.e2 (2015).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016132_CR145","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1053\/j.gastro.2015.03.021","volume":"148","author":"E Liaskou","year":"2015","unstructured":"Liaskou, E. & Hirschfield, G. M. Genetic distinctions in patients with primary sclerosing cholangitis: immunoglobulin G4 elevations and HLA risk. Gastroenterology 148, 886\u2013889 (2015).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2016132_CR146","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1007\/s00261-015-0543-4","volume":"40","author":"CS Gardner","year":"2015","unstructured":"Gardner, C. S. et al. Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy. Abdom. Imaging 40, 3052\u20133061 (2015).","journal-title":"Abdom. Imaging"},{"key":"BFnrgastro2016132_CR147","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nrgastro.2009.46","volume":"6","author":"P Ruemmele","year":"2009","unstructured":"Ruemmele, P., Hofstaedter, F. & Gelbmann, C. M. Secondary sclerosing cholangitis. Nat. Rev. Gastroenterol. Hepatol. 6, 287\u2013295 (2009).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016132_CR148","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S1542-3565(03)00221-0","volume":"1","author":"K Hirano","year":"2003","unstructured":"Hirano, K. et al. Involvement of the biliary system in autoimmune pancreatitis: A follow-up study. Clin. Gastroenterol. Hepatol. 1, 453\u2013464 (2003).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2016132_CR149","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/bjs.6057","volume":"95","author":"D Erdogan","year":"2008","unstructured":"Erdogan, D. et al. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br. J. Surg. 95, 727\u2013734 (2008).","journal-title":"Br. J. Surg."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2016.132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2016.132","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2016.132.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T03:15:43Z","timestamp":1692501343000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2016.132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,14]]},"references-count":149,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFnrgastro2016132"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2016.132","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,14]]},"assertion":[{"value":"14 September 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}